TWI244921B - Oral administration medicine with improving absorbability - Google Patents

Oral administration medicine with improving absorbability Download PDF

Info

Publication number
TWI244921B
TWI244921B TW091120354A TW91120354A TWI244921B TW I244921 B TWI244921 B TW I244921B TW 091120354 A TW091120354 A TW 091120354A TW 91120354 A TW91120354 A TW 91120354A TW I244921 B TWI244921 B TW I244921B
Authority
TW
Taiwan
Prior art keywords
vitamin
tocopherol
weight
fat
patent application
Prior art date
Application number
TW091120354A
Other languages
English (en)
Chinese (zh)
Inventor
Minoru Okada
Haruo Sugata
Toshiaki Horie
Tetsuo Kaneko
Original Assignee
Ssp Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ssp Co Ltd filed Critical Ssp Co Ltd
Application granted granted Critical
Publication of TWI244921B publication Critical patent/TWI244921B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW091120354A 2001-10-11 2002-09-05 Oral administration medicine with improving absorbability TWI244921B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤

Publications (1)

Publication Number Publication Date
TWI244921B true TWI244921B (en) 2005-12-11

Family

ID=19132362

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091120354A TWI244921B (en) 2001-10-11 2002-09-05 Oral administration medicine with improving absorbability

Country Status (5)

Country Link
JP (1) JP2003119141A (es)
KR (1) KR20030030882A (es)
CN (1) CN1219514C (es)
HK (1) HK1054695A1 (es)
TW (1) TWI244921B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4780907B2 (ja) * 2003-09-30 2011-09-28 小林製薬株式会社 催眠剤組成物
JP4721631B2 (ja) * 2003-09-30 2011-07-13 小林製薬株式会社 催眠剤組成物
JP5094899B2 (ja) * 2010-03-23 2012-12-12 小林製薬株式会社 催眠剤組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151132A (ja) * 1984-12-24 1986-07-09 Kanebo Ltd ビタミンｋ↓２経口剤の製造法
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPH10130171A (ja) * 1996-09-04 1998-05-19 Dot:Kk 経口投与用医薬組成物
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
CN1411812A (zh) 2003-04-23
JP2003119141A (ja) 2003-04-23
CN1219514C (zh) 2005-09-21
KR20030030882A (ko) 2003-04-18
HK1054695A1 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
US8703725B2 (en) Nutritional compositions
JP6346896B2 (ja) カルシウムβ−ヒドロキシ−β−メチルブチレート、タンパク質および低レベルの電解質を含む栄養組成物
TWI429405B (zh) 用於靜脈營養療法的小兒胺基酸溶液
CA2436764C (en) Rehydration composition
JP2005529980A (ja) 代謝ストレスを受けている哺乳動物における異化を治療または予防し、同化を促進する方法及び組成物
JPH11500725A (ja) ピペリンのバイオアベイラビリティ増強剤としての使用
JP2005505500A (ja) 無月経及び関連疾患を治療するためのタンパク質及び必須アミノ酸の使用
TW200812594A (en) Medicine for prevention of and/or recovery from fatigue
JP2006241140A (ja) 肝疾患用栄養組成物
CN106616959A (zh) 用于器官移植围手术期患者的肠内营养制剂及其制备方法
CN109619308A (zh) 一种用于提高猫咪免疫力来预防猫鼻之的营养膏配方及其制备方法
TWI244921B (en) Oral administration medicine with improving absorbability
CN105581331B (zh) 一种补钙营养组合物
BRPI0413618B1 (pt) xarope multivitamínico para crianças ou adolescentes
JP3908513B2 (ja) 肝機能改善剤
JP6196847B2 (ja) 防已含有組成物
JP5961034B2 (ja) 安定化方法
JP2004210639A (ja) 経口栄養剤
JP2011068647A (ja) アスパラギン酸又はその塩含有固形製剤
JP2014214141A (ja) 防已含有組成物
CN108719998A (zh) 一种用于治疗骨关节炎的口服膳食补充药剂
JP5114394B2 (ja) 疲労回復のための医薬
JPH07267855A (ja) グルタミン産生剤
JP7489071B2 (ja) 経口ゲル状組成物
JP2011068614A (ja) ビタミン製剤

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees